An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine protects against COVID-19, setting the stage for a vote on the shot. The report confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. https://t.co/KSpy2gler7